Haemonetics Corporation (HAE)
Gross profit margin
Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross profit (ttm) | US$ in thousands | 748,958 | 727,507 | 711,827 | 694,900 | 687,241 | 671,891 | 652,731 | 640,099 | 615,097 | 595,159 | 575,017 | 539,680 | 505,502 | 450,998 | 432,690 | 415,893 | 397,838 | 429,588 | 437,381 | 458,637 |
Revenue (ttm) | US$ in thousands | 1,360,824 | 1,373,515 | 1,361,223 | 1,333,895 | 1,309,055 | 1,270,181 | 1,239,232 | 1,218,534 | 1,168,660 | 1,129,246 | 1,083,714 | 1,026,126 | 993,196 | 953,223 | 933,825 | 903,414 | 870,463 | 883,926 | 902,525 | 945,605 |
Gross profit margin | 55.04% | 52.97% | 52.29% | 52.10% | 52.50% | 52.90% | 52.67% | 52.53% | 52.63% | 52.70% | 53.06% | 52.59% | 50.90% | 47.31% | 46.34% | 46.04% | 45.70% | 48.60% | 48.46% | 48.50% |
March 31, 2025 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $748,958K ÷ $1,360,824K
= 55.04%
Based on the data provided, Haemonetics Corporation's gross profit margin has shown fluctuations over the period from June 30, 2020, to March 31, 2025. The gross profit margin started at 48.50% in June 2020, experienced some variations, and then increased steadily over time.
There was a slight dip in the gross profit margin to 45.70% in March 2021, possibly due to changes in costs or pricing strategies. However, from that point on, the gross profit margin showed a positive trend, with consistent improvements quarter over quarter.
The company's gross profit margin reached a peak of 55.04% in March 2025, indicating that the company was effectively managing its production costs and generating more revenue from its core operations. This improvement suggests that Haemonetics Corporation was able to increase its profitability by either reducing costs, increasing prices, or a combination of both.
Overall, the trend in Haemonetics Corporation's gross profit margin is positive and demonstrates the company's ability to maintain healthy margins and improve operational efficiency over the analyzed period.
Peer comparison
Mar 31, 2025